Search Articles

View query in Help articles search

Search Results (1 to 10 of 100 Results)

Download search results: CSV END BibTex RIS


Effectiveness of a WeChat Mini Program–Based Intervention on Promoting Multiple Health Behavior Changes Among Chinese Patients With Cardiovascular Diseases in Home-Based Rehabilitation: Randomized Controlled Trial

Effectiveness of a WeChat Mini Program–Based Intervention on Promoting Multiple Health Behavior Changes Among Chinese Patients With Cardiovascular Diseases in Home-Based Rehabilitation: Randomized Controlled Trial

Cardiovascular diseases (CVDs), the leading cause of mortality globally, encompass a variety of disorders that impair the heart and blood vessels (eg, coronary heart disease, cerebrovascular disease, and peripheral arterial disease) [1,2]. In China, approximately 330 million individuals are afflicted with CVDs, constituting 46.9% of total annual deaths [3].

Yanping Duan, Wei Liang, Lan Guo, Huimin Zhan, Chunli Xia, Huan Ma, Borui Shang, Yanping Wang, Min Yang, Shishi Cheng

J Med Internet Res 2025;27:e66249

Experience of Cardiovascular and Cerebrovascular Disease Surgery Patients: Sentiment Analysis Using the Korean Bidirectional Encoder Representations from Transformers (KoBERT) Model

Experience of Cardiovascular and Cerebrovascular Disease Surgery Patients: Sentiment Analysis Using the Korean Bidirectional Encoder Representations from Transformers (KoBERT) Model

Data pertaining to cerebrovascular and cardiovascular surgeries were visualized and analyzed using word clouds (Multimedia Appendix 2). For cerebrovascular surgery patients, the prominent keywords were “surgery,” “hospital,” “test,” “receive,” and “symptom.” For cardiovascular surgery patients, the key terms that emerged were “surgery,” “hospital,” “receive,” “eat,” “admission,” and “symptom.”

Hocheol Lee, Yu Seong Hwang, Ye Jun Kim, Yukyung Park, Heui Sug Jo

JMIR Med Inform 2025;13:e65127

Augmenting Engagement in Decentralized Clinical Trials for Atrial Fibrillation: Development and Implementation of a Programmatic Architecture

Augmenting Engagement in Decentralized Clinical Trials for Atrial Fibrillation: Development and Implementation of a Programmatic Architecture

Women, racial and ethnic minorities, and people who reside in rural settings have historically been underrepresented in randomized clinical trials testing or evaluating interventions for cardiovascular diseases [2-6]. Causes of such underrepresentation are multifactorial and related to the individual or patient, investigator, and health care system factors [1,7,8].

Toluwa Daniel Omole, Andrew Mrkva, Danielle Ferry, Erin Shepherd, Jessica Caratelli, Noah Davis, Richmond Akatue, Timothy Bickmore, Michael K Paasche-Orlow, Jared W Magnani

JMIR Cardio 2025;9:e66436

Wearable Devices in Remote Cardiac Rehabilitation With and Without Weekly Online Coaching for Patients With Coronary Artery Disease: Randomized Controlled Trial

Wearable Devices in Remote Cardiac Rehabilitation With and Without Weekly Online Coaching for Patients With Coronary Artery Disease: Randomized Controlled Trial

Recently, several studies have reported a negative correlation between cardiovascular disease risk and physical activity measured using wearable devices and a smartphone [7-9]. Furthermore, smartphone-based home CR programs have been shown to enhance participation and adherence and improve both physiological and psychological health outcomes [10].

Ryota Nishio, Tomotaka Dohi, Miho Yokoyama, Taisuke Nakade, Norihito Takahashi, Yuichi Chikata, Hirohisa Endo, Hiroki Nishiyama, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, Katsumi Miyauchi, Hiroyuki Daida, Tohru Minamino

JMIR Mhealth Uhealth 2025;13:e63797

Examining Practices Related to Ethical Aspects in eHealth Evaluation Research: Protocol for a Scoping Review

Examining Practices Related to Ethical Aspects in eHealth Evaluation Research: Protocol for a Scoping Review

RPM shows particular promise in the care of cancer [3,4] and cardiovascular diseases [5], as these conditions often require prompt intervention when health issues arise. Together, they account for more than half of global mortality, with 33% attributed to cancer and 18% to cardiovascular diseases [6].

Linda Wienands, Sabine Valenta, Lynn Leppla, Sabina De Geest, László Kovács, Alexandra Teynor, Julia Krumme

JMIR Res Protoc 2025;14:e60849

Interventions to Reduce Serum Per- and Poly-Fluoroalkyl Substances Levels, Improve Cardiovascular Risk Profiles, and Improve Epigenetic Age Acceleration in US Firefighters: Protocol for Randomized Controlled Trial

Interventions to Reduce Serum Per- and Poly-Fluoroalkyl Substances Levels, Improve Cardiovascular Risk Profiles, and Improve Epigenetic Age Acceleration in US Firefighters: Protocol for Randomized Controlled Trial

Zone 2 physical activity, or continuous, moderate aerobic physical activity corresponding to the near lactate threshold (4 m M blood lactate), shows greater benefits than other types of aerobic physical activity for improving cardiovascular risk factors [20,21]. Common examples of this type of activity include brisk walks, light jogs, and cycling for a continuous interval of time.

Reagan Conner, Cynthia Porter, Karen Lutrick, Shawn C Beitel, James Hollister, Olivia Healy, Krystal J Kern, Floris Wardenaar, John J Gulotta, Kepra Jack, Matthew Huentelman, Jefferey L Burgess, Melissa Furlong

JMIR Res Protoc 2025;14:e67120

The Role of AI in Cardiovascular Event Monitoring and Early Detection: Scoping Literature Review

The Role of AI in Cardiovascular Event Monitoring and Early Detection: Scoping Literature Review

This capability could be especially significant in the context of cardiology, the specific subject of our study, helping to provide a more comprehensive understanding of a patient’s cardiovascular health. Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide [7]. Globally, CVDs account for approximately 17.9 million deaths annually, representing 32% of all global deaths [8].

Luis B Elvas, Ana Almeida, Joao C Ferreira

JMIR Med Inform 2025;13:e64349

Exploring Stakeholder Perspectives on the Barriers and Facilitators of Implementing Digital Technologies for Heart Disease Diagnosis: Qualitative Study

Exploring Stakeholder Perspectives on the Barriers and Facilitators of Implementing Digital Technologies for Heart Disease Diagnosis: Qualitative Study

Cardiovascular medicine has been one of the earliest adopters of digital technology in health care because aspects of cardiovascular health, such as electrocardiograms (ECGs), are already proven to be clinically relevant and are measurable using both medical devices and consumer wearables [4-6].

Kamilla Abdullayev, Tim J A Chico, Jiana Canson, Matthew Mantelow, Oli Buckley, Joan Condell, Richard J Van Arkel, Vanessa Diaz-Zuccarini, Faith Matcham

JMIR Cardio 2025;9:e66464